Media

Learn more about us in our featured news stories and insights into the work that we do.

News Press Releases Locus Insights

January 24, 2022

Deep Dive: Deep Dive Into Bacteriophage’s Potential

Learn More
January 10, 2022

Precision Approach To Infectious Disease With Locus Biosciences’ Paul Garofolo

Learn More
October 19, 2021

Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital. Proceeds to be used to advance development of synthetic biology engine and manufacturing capabilities

Learn More
April 27, 2021

2021 ISPE Facility of the Year Award Winners

Learn More
April 25, 2021

It’s DNA Day! Here Are 4 Ways Gene Editing Is Transforming Medicine

Learn More
March 8, 2021

New clinical trial data from Locus Biosciences shows promise in CRISPR-Cas3 technology

Learn More
March 5, 2021

Could this Research Triangle Park company hold a key to fighting drug-resistant bacteria?

Learn More
February 24, 2021

Locus Biosciences completes first-of-its-kind controlled clinical trial for CRISPR-enhanced bacteriophage therapy

Learn More
February 24, 2021

Genetically enhanced antibiotic from RTP firm advances in first-of-its-kind clinical trial

Learn More
December 17, 2020

Gene editing success could turn Triangle startup Locus Biosciences into a billion dollar unicorn

Learn More

Careers

We are on a mission to revolutionize the treatment of disease. We need intelligent, open, hard-working people who thrive in a fast-paced environment to join us on our quest.